Drug Shortage Report for DALACIN C 300 MG

Last updated on 2020-08-26 History
Report ID 118995
Drug Identification Number 02182866
Brand name DALACIN C 300 MG
Common or Proper name DALACIN C 300MG
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-06-30
Estimated end date
Actual end date 2020-08-25
Shortage status Resolved
Updated date 2020-08-26
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-08-26 French Compare
v6 2020-08-26 English Compare
v5 2020-08-19 French Compare
v4 2020-08-19 English Compare
v3 2020-07-01 English Compare
v2 2020-06-26 French Compare
v1 2020-06-26 English Compare